Latest California Healthline Stories
Among other issues, some pharmacists in the state are confused about the new law — with one saying that it was only an option in Oregon — and that others need to be trained to prescribe the contraception. Thus, more than 18 months after the bill was signed into law, many women are struggling to find a pharmacy that offers the option.
Poll Finds Concerns Growing Among Obamacare Enrollees About Premium, Deductible Costs
The survey by the Kaiser Family Foundation identifies rising concerns about the prices for medical services and insurance.
Doctors Weigh In On Ethical, Practical Questions Surrounding Aid-In-Dying Law
Some in the palliative care field are welcoming the law after years of debate, while others say that the law goes directly against a doctor’s instinct. KPCC hosts a panel of doctors to discuss the issue.
House Passes $622M For Zika Funding, But CDC Says ‘It’s Just Not Enough’
On Tuesday the Senate passed its own $1.1 billion bill, and the two chambers are now facing tough negotiations in an effort to find a compromise. Meanwhile, the man who led the White House response to Ebola says Congress has failed to learn its lesson and is now failing Americans in the face of a slow-motion public-health disaster.
Kern County Prisons Implement Law Providing Free Condoms To Inmates
The state law, signed in 2014, had a slow rollout. The legislation is targeted at both protecting the health of the inmates and the cost to the taxpayers. Treatment of infectious diseases is far pricier than the condoms.
Researchers: Origin Point Of Colon Tumor More Important Than Anyone Expected
In a new study, cancer patients whose tumor bloomed on the left side of their colon survived a median of 33.3 months, while right-sided colon cancer patients survived 19.4 months.
In Effort To Curb Overdose Deaths, Ventura Doctors Urged To Use Statewide CURES Database
The system tracks who has been prescribed those drugs most prone to addiction and abuse.
State Agency Reviewing Toxic Contamination Decisions After Racially Charged Emails Come To Light
Activists say the emails reveal a systemic bias against communities of color facing possible toxic contamination.
New Immunotherapy Is First Bladder Cancer Drug Approved By FDA In 30 Years
San Francisco-based Genentech Inc.’s new drug, Tecentriq, is expected to treat patients metastatic bladder cancer. Meanwhile, new research identifying breast cancer genes could aid treatment plans.
CEO Of Nonprofit Health Network Accused Of Scrimping On Quality Care To Pad Profits
Nikhil Gupta is described as running “a one-man show” at Mission City Community Network in North Hills and that staff and the board are afraid to challenge his decisions, some of which might compromise care. His $763,656 in annual pay is two to three times greater than that of other executives running larger clinics in California.